Status:
COMPLETED
Characteristics of Pneumothorax Associated With Transthoracic Percutaneous Lung Biopsy in Standard of Care
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Pneumothorax Iatrogenic Postprocedural
Eligibility:
All Genders
18+ years
Brief Summary
The number of lung biopsies has increased steadily in recent years. Pneumothorax is the most common complication of a lung biopsy and can occur during the procedure, immediately after the procedure or...
Eligibility Criteria
Inclusion
- Patients aged 18 years old and more at the time of the biopsy procedure in year 2020
- Having had a pneumothorax following their transthoracic percutaneous lung biopsy in year 2020
Exclusion
- Objection to the use of the data (French sites only)
Key Trial Info
Start Date :
December 9 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
243 Patients enrolled
Trial Details
Trial ID
NCT05259293
Start Date
December 9 2021
End Date
December 31 2022
Last Update
September 19 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Besançon
Besançon, France
2
Institut Bergonié
Bordeaux, France
3
CHU de Tours
Tours, France
4
Institut Gustave Roussy
Villejuif, France